476
Participants
Start Date
May 29, 2024
Primary Completion Date
June 25, 2031
Study Completion Date
June 25, 2032
Orelabrutinib
Eligible patients will receive Orelabrutinib orally as per the protocol，until disease progression or other reasons for treatment discontinuation，whichever comes first.
Bendamustine Injection
Eligible patients will receive Bendamustine by injection as per the protocol
Rituximab
Eligible patients will receive Rituximab by injection as per the protocol
Orelabrutinib Placebo
Eligible patients will receive Orelabrutinib Placebo orally as per the protocol
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Peking University Third Hospital, Beijing
RECRUITING
The First Affiliated Hospital of Bengbu Medical University, Bengbu
NOT_YET_RECRUITING
First Hospital of Jilin University, Changchun
RECRUITING
Hunan Cancer Hospital, Changsha
NOT_YET_RECRUITING
The First People's Hospital of Changzhou, Changzhou
RECRUITING
Sichuan Provincial People's Hospital, Chengdu
NOT_YET_RECRUITING
West China Hospital of Sichuan University, Chengdu
RECRUITING
Chongqinq Cancer Hospital, Chongqing
NOT_YET_RECRUITING
The First Affiliated Hospital of Chongqing Medical University, Chongqing
NOT_YET_RECRUITING
The second Hospital of Dalian Medical University, Dalian
RECRUITING
Fujing Cancer Hospital, Fuzhou
NOT_YET_RECRUITING
Union Hospital Affiliated to Fujian Medical University, Fuzhou
RECRUITING
Guangdong Provincial People's Hospital, Guangzhou
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
NOT_YET_RECRUITING
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
RECRUITING
Zhejiang University Medical School affiliated to the first Hospital, Hangzhou
RECRUITING
The First Affiliated Hospital of Anhui Medical University, Hefei
NOT_YET_RECRUITING
Cancer Hospital of Shandong First Medical University, Jinan
NOT_YET_RECRUITING
Shandong Provincial Hospital, Jinan
RECRUITING
The First Affiliated Hospital of Ningbo University, Jinan
NOT_YET_RECRUITING
The First Affiliated Hospital of Henan University of Science & Technology, Luoyang
RECRUITING
The First Affiliated Hospital of Nanchang University, Nanchang
NOT_YET_RECRUITING
Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University, Nanjing
NOT_YET_RECRUITING
Cancer Hospital Affiliated to Fudan University, Shanghai
RECRUITING
Huashan Hospital of Fudan University, Shanghai
NOT_YET_RECRUITING
Shengjing Hospital of China Medical University, Shenyang
RECRUITING
The First Affiliated Hospital of China Medical University, Shenyang
NOT_YET_RECRUITING
The Fourth Hospital of Hebei Medical University, Shijiazhuang
NOT_YET_RECRUITING
Shanxi Cancer Hospital, Taiyuan
RECRUITING
Tianjin Cancer Hospital, Tianjin
RECRUITING
The Tumor Hospital Affiliated to Xinjiang Medical University, Ürümqi
RECRUITING
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and, Wuhan
NOT_YET_RECRUITING
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and, Wuhan
NOT_YET_RECRUITING
The First Affiliated Hospital of the PLA Air Force Military Medical University (Xijing Hospital), Xi'an
NOT_YET_RECRUITING
The Second Affiliated Hospital Of Xi'an Jiaotong University, Xi'an
NOT_YET_RECRUITING
Yibin Second People's Hospital, Yibin
RECRUITING
Henan Cancer Hospital, Zhengzhou
NOT_YET_RECRUITING
Henan Provincial People's Hospital, Zhengzhou
Lead Sponsor
InnoCare Pharma Inc.
INDUSTRY